IXJ Among Health Care ETFs
End-of-day Nov 17, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −1.9% | +5.9% | +5.0% | +16.8% | +19.7% | +46.2% | +38.1% | +177.0% | +466.5% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$116 of every $1,000 in IXJ is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 11.57% | $1,156.80 | 381K | $545.7M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.88% | $687.57 | 1.1M | $324.3M |
| 3 | ABBVAbbvie | Healthcare | 5.26% | $525.59 | 842K | $247.9M |
| 4 | UNHUnitedhealth Group | Healthcare | 4.11% | $410.65 | 470K | $193.7M |
| 5 | MRKMerck | Healthcare | 3.95% | $395.16 | 1.3M | $186.4M |
| 6 | ROP.SWRoche PS PAR AG | Healthcare | 3.81% | $380.50 | 368K | $179.5M |
| 7 | NOVN.SWNovartis AG | Healthcare | 3.29% | $328.98 | 959K | $155.2M |
| 8 | AZN.LAstrazeneca | Healthcare | 3.19% | $318.69 | 812K | $150.3M |
| 9 | TMOThermo Fisher Scientific | Healthcare | 2.84% | $283.85 | 194K | $133.9M |
| 10 | AMGNAmgen | Healthcare | 2.78% | $277.53 | 283K | $130.9M |
| 11 | GILDGilead Sciences | Healthcare | 2.31% | $230.80 | 650K | $108.9M |
| 12 | ABTAbbott Laboratories | Healthcare | 2.06% | $206.45 | 906K | $97.4M |
| 13 | PFEPfizer | Healthcare | 1.83% | $182.65 | 3.0M | $86.2M |
| 14 | ISRGIntuitive Surgical | Healthcare | 1.72% | $171.81 | 185K | $81.0M |
| 15 | DHRDanaher | Healthcare | 1.60% | $159.72 | 328K | $75.3M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly | 11.57% |
| 2 | JNJ | Johnson & Johnson | 6.88% |
| 3 | ABBV | Abbvie | 5.26% |
| 4 | UNH | Unitedhealth Group | 4.11% |
| 5 | MRK | Merck & | 3.95% |
| 6 | ROP.SW | Roche PS PAR AG | 3.81% |
| 7 | NOVN.SW | Novartis AG | 3.29% |
| 8 | AZN.L | Astrazeneca | 3.19% |
| 9 | TMO | Thermo Fisher Scientific | 2.84% |
| 10 | AMGN | Amgen | 2.78% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.85 |
| Dec 16, 2025 | Dec 19, 2025 | $0.60 |
| Jun 16, 2025 | Jun 20, 2025 | $0.76 |
| Dec 17, 2024 | Dec 20, 2024 | $0.62 |
| Jun 11, 2024 | Jun 17, 2024 | $0.67 |
| Dec 20, 2023 | Dec 27, 2023 | $0.56 |
| Jun 7, 2023 | Jun 13, 2023 | $0.64 |
| Dec 13, 2022 | Dec 19, 2022 | $0.44 |
| Jun 9, 2022 | Jun 15, 2022 | $0.55 |
| Dec 13, 2021 | Dec 17, 2021 | $0.48 |
| Jun 10, 2021 | Jun 16, 2021 | $0.53 |
| Dec 14, 2020 | Dec 18, 2020 | $0.44 |